Recurrent Myeloproliferative Neoplasm
4 clinical trials · Condition
◉ Watch Recurrent Myeloproliferative Neoplasm
| Record | Firm | Date |
|---|---|---|
| Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia (NCT04250051) | Northwestern University | 2020-12-21 |
| Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations (NCT04493138) | M.D. Anderson Cancer Center | 2020-07-21 |
| Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial (NCT03878524) | OHSU Knight Cancer Institute | 2020-04-01 |
Track Recurrent Myeloproliferative Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.